Indatens

Indapamide, the active ingredient in Indatens, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower elevated blood pressure and to reduce fluid accumulation in patients with heart‑failure‑related edema.

GNH USA supplies Indatens as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts on the renal distal convoluted tubule to manage conditions characterized by excess fluid or elevated blood pressure. - Hypertension: lowers systemic blood pressure by promoting sodium and water excretion. - Edema associated with heart failure: reduces fluid overload and peripheral swelling. - Edema secondary to renal disease: aids in removing excess extracellular fluid and improving symptom control.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urinary frequency - Electrolyte disturbances, especially low potassium - Muscle cramps or weakness - Fatigue

Serious or Rare Side Effects: - Severe dehydration or hypotension - Hyponatremia or severe electrolyte imbalance - Hyperuricemia leading to gout attacks - Allergic reactions such as rash or angioedema - Blood dyscrasias including leukopenia - Acute pancreatitis

Before initiating therapy, clinicians should consider several safety measures. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Electrolyte assessment: regularly check serum potassium and sodium levels. - Renal function evaluation: adjust use in patients with impaired kidney function. - Diabetes caution: monitor blood glucose as diuretics may affect glycemic control. - Elderly patients: start at lower doses and observe for orthostatic symptoms. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Indapamide can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity due to reduced renal clearance. - Cyclosporine: heightened nephrotoxic potential and electrolyte disturbances. - High‑dose NSAIDs: may blunt diuretic effect and worsen renal function.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: enhanced hypoglycemic effect, requiring dose adjustment. - ACE inhibitors or ARBs: additive blood‑pressure lowering, monitor for hypotension. - Anticoagulants (e.g., warfarin): possible increase in INR, necessitating closer coagulation monitoring.